- Moderna and a handful of its collaborators at the National Institutes of Health (NIH) seemed to know that Moderna’s miracle had arrived — well before anyone else knew or could have known
- Moderna’s CEO Stéphane Bancel emailed the director of the NIH and asked to be sent the genetic sequence for what would become known as SAR-CoV-2, allegedly because media reports on the outbreak “troubled” him
- In order to begin its human trial, regulatory agencies had to allow Moderna to bypass major aspects of traditional animal trials, which many experts and commentators noted was highly unusual but was now deemed necessary due to the urgency of the crisis
- Instead of developing the vaccine in distinct sequential stages, as is the custom, Moderna “decided to do all of the steps [relating to animal trials] simultaneously”
- US taxpayers may have an ownership stake in vaccines made and sold by Moderna
See the full story here.